Trial · NCT02002819
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Changes in Executive Function as Measured by the NIH EXAMINER Computer Battery | Levetiracetam | -0.06 | 95% Confidence Interval -0.24 to 0.11 | score on a scale | |
| Changes in Executive Function as Measured by the NIH EXAMINER Computer Battery | Placebo | -0.14 | 95% Confidence Interval -0.32 to 0.05 | score on a scale | |
| Changes in Stroop Interference Naming | Levetiracetam | 1.5 | 95% Confidence Interval -1.4 to 4.3 | score on a scale | |
| Changes in Stroop Interference Naming | Placebo | -1.4 | 95% Confidence Interval -3.6 to 0.7 | score on a scale | |
| Changes in ADAS-cog | Levetiracetam | -0.2 | 95% Confidence Interval -1.8 to 1.5 | score on a scale | |
| Changes in ADAS-cog | Placebo | 0.8 | 95% Confidence Interval -0.7 to 2.3 | score on a scale | |
| Clinical Dementia Rating Sum of Boxes (CDR-SOB) | Levetiracetam | 0.1 | 95% Confidence Interval -0.1 to 0.3 | score on a scale | |
| Clinical Dementia Rating Sum of Boxes (CDR-SOB) | Placebo | 0.1 | 95% Confidence Interval -0.2 to 0.3 | score on a scale | |
| Changes in Behavior and Level of Disability - ADCS-ADL | Levetiracetam | 0.4 | 95% Confidence Interval -0.9 to 1.6 | score on a scale | |
| Changes in Behavior and Level of Disability - ADCS-ADL | Placebo | 0.3 | 95% Confidence Interval -0.9 to 1.5 | score on a scale | |
| Changes in Behavior and Level of Disability - ADCS-CGIC | Levetiracetam | 4.0 | 95% Confidence Interval 3.8 to 4.3 | score on a scale | |
| Changes in Behavior and Level of Disability - ADCS-CGIC | Placebo | 4.0 | 95% Confidence Interval 3.7 to 4.3 | score on a scale | |
| Changes in Behavior and Level of Disability - Neuropsychiatric Inventory (NPI) | Levetiracetam | -0.8 | 95% Confidence Interval -2.7 to 1.2 | score on a scale | |
| Changes in Behavior and Level of Disability - Neuropsychiatric Inventory (NPI) | Placebo | 0.2 | 95% Confidence Interval -2.2 to 2.6 | score on a scale | |
| Changes in Epileptiform Events | Levetiracetam | -0.1 | 95% Confidence Interval -0.4 to 0.1 | Epileptiform events | |
| Changes in Epileptiform Events | Placebo | -0.2 | 95% Confidence Interval -1.1 to 0.6 | Epileptiform events | |
| Stroop Interference in AD With Epileptiform Activity | Levetiracetam (Epileptiform Activity) | 4.7 | Standard Deviation 7.2 | score on a scale | |
| Stroop Interference in AD With Epileptiform Activity | Placebo (Epileptiform Activity) | -2.6 | Standard Deviation 5.0 | score on a scale | |
| ADAS-cog in AD With Epileptiform Activity | Levetiracetam (Epileptiform Activity) | -1.0 | Standard Deviation 4.1 | score on a scale | |
| ADAS-cog in AD With Epileptiform Activity | Placebo (Epileptiform Activity) | 1.5 | Standard Deviation 4.5 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02002819/results